Zynerba Pharma (ZYNE) – Management Comments
-
Zynerba Pharma (ZYNE) Provides Regulatory Update on Zygel in Fragile X Syndrome
-
Zynerba Pharma (ZYNE) Presents Phase 2 BELIEVE Safety, Efficacy & Quality of Life Data in Developmental and Epileptic Encephalopathies at 2020 AAN Virtual Meetings
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ZYNE Stock Lookup